Shandong Jishi Pharmaceutical Technology Co., Ltd. (山东基石医药科技有限公司) is a medical diagnostics and pharmaceutical technology enterprise based in Zaozhuang, Shandong Province, China. The company operates at the intersection of medical diagnostics, laboratory services, and pharmaceutical research, with a focus on providing clinical testing, disease screening, and customized medical solutions to hospitals, research institutes, and public health authorities.
Core Business
Shandong Jishi Pharmaceutical Technology's operations are concentrated in:
- Medical Diagnostic Services
- Clinical Laboratory Testing
- Health Screening Programs
- Pharmaceutical R&D Support
- Public Health Monitoring
The company is positioned as a core service provider to both public and private healthcare systems, delivering precision diagnostic data and laboratory support.
Product and Service Offerings
While detailed product listings are not publicly disclosed, Jishi Pharmaceutical's primary services include:
1. Clinical Diagnostics and Laboratory Testing
- Biochemical and immunological assays
- Infectious disease testing
- Tumor marker detection
- Routine hematological and biochemical testing
2. Public Health Screening
- Community-level disease prevention programs
- Early detection screening for chronic and infectious diseases
- Health record integration and diagnostic data management
3. Pharmaceutical Research Support
- Laboratory analysis for clinical trials
- Bioanalytical and pharmacokinetics testing
- Sample collection and high-precision analytics
The company serves as a collaborative platform for both clinical institutions and pharmaceutical companies in need of laboratory-based services and real-world evidence generation.
Specialisation and Core USP
Jishi Pharmaceutical's competitive strengths include:
- High-throughput diagnostic capability: Equipped with automated analyzers and precision instruments
- Integrated data systems: Diagnostic data seamlessly linked with electronic medical records (EMRs)
- Collaboration with public health authorities: Key partner in regional disease surveillance and prevention efforts
- Expert medical team: Staffed with qualified pathologists, lab technicians, and healthcare researchers
- Regional reach: Provides services across multiple districts in Shandong and surrounding provinces
Financials
As a privately held company, financial data is not disclosed; however:
- Estimated Annual Revenue: USD 3–6 million, based on scale of regional diagnostic operations
- Revenue Drivers: Clinical testing services and health screening programs under government and hospital contracts
- Growth Trend: Steady increase in testing volume post-COVID due to rising demand for diagnostics and early screening
The company operates on a service-based revenue model with volume-based testing driving its margins.
Shipment Data
Jishi Pharmaceutical is primarily a service provider and not engaged in physical product export; therefore:
- Export Volume: Not applicable
- Service Delivery: Fully domestic and regional (Shandong and surrounding regions)
Target Market
Jishi Pharmaceutical primarily serves:
- Public Hospitals and Clinics
- Community Health Centers
- Research Institutions
- Pharmaceutical Companies Conducting Trials
- Local Government Health Agencies
The company supports both routine diagnostics and specialized health initiatives through lab-based interventions.
Capabilities
- Automated Laboratory Systems: Biochemical analyzers, immunoassay systems, PCR-based molecular testing units
- Data Management: Health informatics systems integrated with hospital platforms
- Sample Handling: Cold chain-enabled logistics for sample collection and transport
- Staff Capacity: Medical technologists, licensed pathologists, epidemiologists, and data analysts
- Facility Infrastructure: Biosafety labs and cleanroom environments for high-sensitivity diagnostics
These capabilities enable Jishi to meet diverse client needs ranging from community health diagnostics to pharmaceutical research analytics.
Certifications and Compliance Records
While specific certifications are not publicly listed, it is presumed that the company operates under:
- China National Clinical Laboratory Certification (CNAS)
- GMP Guidelines for Diagnostic Labs
- Health Commission Registrations and Oversight
- Ethics Compliance for Research Involvement
All services are presumed to comply with local and national healthcare regulations and bioethics standards.
Customer Testimonials
Although public testimonials are not available, partnerships and service continuity with hospitals and health authorities indicate:
- “Reliable diagnostic partner for high-volume health screening campaigns”
- “Professional staff with accurate reporting and fast turnaround”
- “Valuable technical support during pharmaceutical clinical trials”
Such feedback reflects sustained satisfaction from institutional clients and government agencies.
Major Achievements
- Recognized as a regional medical testing hub in southern Shandong
- Played a critical role in COVID-19 response diagnostics and epidemiological tracing
- Partnered with multiple county-level hospitals to enhance local diagnostic infrastructure
- Supported pharmaceutical clinical studies with sample testing and analytics
- Contributed to chronic disease prevention initiatives through mass screening services
Shandong Jishi Pharmaceutical Technology Co., Ltd. is strategically positioned to support the evolving needs of China’s healthcare and medical research ecosystem. Through diagnostic innovation, data-driven health programs, and clinical R&D services, the company continues to contribute to precision medicine and public health advancement across the region.